Company Less


to get instant updates about 'Biocon' on your MyPage. Meet other similar minded people. Its Free!


All Updates

Biocon Limited () is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization. Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. In research services, Syngene International Limited (Syngene) is engaged in the business of custom research in drug discovery while the other fully owned subsidiary Clinigene International Limited (Clinigene) is in the clinical development space. In December 2009, Biocon acquired the Active Pharma Ingredients (API) undertaking from IDL Speciality Chemicals Ltd., a subsidiary of Gulf Oil Corporation Limited.

Located in Bangalore, India, Biocon has two subsidiaries, , a custom research organization, and , a clinical research organization. Biocon’s presence straddles four main therapeutic areas – Diabetology, Cardiology, Nephrology and Oncology – even as it plans to introduce two new divisions, Comprehensive Care, and Immunotherapy, this year.

Biocon’s cardiology, nephrology, diabetology and oncology products including BESTOR<sup>®</sup>, BASALOGTM, BioMAb EGFR<sup>®</sup>,...
Read More

No feeds found

Posting your question. Please wait!...


No messages found
Suggested Pages
Tell your friends >
about this page
 Create a new Page
for companies, colleges, celebrities or anything you like.Get updates on MyPage.
Create a new Page
 Find your friends
  Find friends on MyPage from